Media Release For Immediate Release 24 April 2015 Hepatitis ACT today welcomed Pharmaceutical Benefits Advisory Committee (PBAC) recommendations to Government to subsidise new antiviral medicines for the treatment of chronic hepatitis C. Executive Officer of Hepatitis ACT, John Didlick said “Access to these new drugs under the Pharmaceutical Benefits Scheme (PBS) is incredibly important and […]
Hepatitis Australia has been made aware that some people living with hepatitis C are seeking to import medicines not yet available under the Pharmaceutical Benefits Scheme in Australia to treat their hepatitis C infection. Hepatitis Australia understands the frustrations caused by the current lack of availability of new hepatitis C treatment drugs in Australia and […]
Media Release 1 April 2015 Prison-based needle syringe program doomed without Government leadership The ACT Government is being urged to show political leadership and retain control over the introduction of a needle syringe program at the Alexander Maconochie Centre – ACT Prison in order to prevent the spread of blood-borne viruses. Hepatitis Australia and Hepatitis ACT today […]
MEDIA RELEASE: 1 April 2015 One step forward, one step back: Mixed feelings about ACT Government’s latest attempt to implement needle exchange policy Hepatitis ACT cautiously welcomes today’s announcement by Corrections Minister Shane Rattenbury that the ACT Government remains committed to the implementation of its prison needle exchange policy. The policy has stalled […]